Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January

Rhea-AI Summary

Helius Medical Technologies (Nasdaq:HSDT) has announced participation in several virtual investor conferences during January 2021. Key events include:

• The Demy-Colton Digital Medicine and Medtech Showcase from January 11-15, with on-demand access starting January 6th.
• The H.C. Wainwright BioConnect Conference from January 11-14, with presentations available on January 11th.
• The Sidoti Winter 2021 Conference on January 13-14, where management will present on January 13th.
• The ICR Conference from January 11-14, with management presenting on January 14th.

Webcasts will be available on Helius' investor relations website.

NEWTOWN, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences in January:

The Demy-Colton Digital Medicine and Medtech Showcase 2021, which is being held virtually from January 11^th-15^th.

• The Company’s presentation will be available on-demand beginning on Wednesday, January 6th at 8:30 a.m. Eastern Time.
  

The H.C. Wainwright BioConnect Conference, which is being held virtually from January 11^th-14^th.

• The Company’s presentation will be available on-demand beginning on Monday, January 11th at 6:00 a.m. Eastern Time.
  

The Sidoti Winter 2021 Investor Conference, which is being held virtually from January 13^th-14^th.

• Management will present on Wednesday, January 13th at 1:45 p.m. Eastern Time.
  

The ICR Conference 2021, which is being held virtually from January 11^th-14^th.

• Management will present on Thursday, January 14th at 10:45 a.m. Eastern Time.
  

Webcasts of the presentations will be provided under the ‘Events’ section of the Helius Medical Technologies investor relations website at https://heliusmedical.com/index.php/investor-relations/events/upcoming-events. Archives of the webcasts will be available for replay following the conference.

About Helius Medical Technologies, Inc.

Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS^TM). For more information, visit www.heliusmedical.com.

About the PoNS™ Device and PoNS Treatment™

The Portable Neuromodulation Stimulator (PoNS™) is authorized for sale in Canada as a class II, non-implantable, medical device intended as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from multiple sclerosis (MS), and chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy. The PoNS™ is an investigational medical device in the United States, the European Union (“EU”), and Australia (“AUS”). The device is currently under review for clearance by the FDA. It is also under premarket review by the AUS Therapeutic Goods Administration. PoNS™ is currently not commercially available in the United States, the European Union or Australia.

Investor Relations Contact:

Westwicke Partners on behalf of Helius Medical Technologies, Inc.
Mike Piccinino, CFA
investorrelations@heliusmedical.com

FAQ

What investor conferences will Helius Medical Technologies participate in January 2021?

Helius Medical Technologies will participate in the Demy-Colton Digital Medicine and Medtech Showcase, H.C. Wainwright BioConnect Conference, Sidoti Winter 2021 Conference, and ICR Conference.

When will Helius Medical Technologies present at the Sidoti Winter 2021 Investor Conference?

Management will present at the Sidoti Winter 2021 Investor Conference on January 13th at 1:45 p.m. Eastern Time.

How can I access the webcasts of Helius Medical Technologies' presentations?

Webcasts of the presentations will be available under the 'Events' section of Helius Medical Technologies' investor relations website.

When will Helius Medical Technologies make its presentation available for the H.C. Wainwright BioConnect Conference?

The presentation will be available on-demand starting January 11th at 6:00 a.m. Eastern Time.

What is the purpose of the Portable Neuromodulation Stimulator (PoNS) device by Helius?

The PoNS device is intended as a short-term treatment for gait deficit due to multiple sclerosis and balance deficit due to traumatic brain injury, used in conjunction with physical therapy.